367 related articles for article (PubMed ID: 36928826)
1. Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions.
Singh I; Singh A
Curr Oncol Rep; 2023 Jun; 25(6):539-547. PubMed ID: 36928826
[TBL] [Abstract][Full Text] [Related]
2. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.
Marnell CS; Bick A; Natarajan P
J Mol Cell Cardiol; 2021 Dec; 161():98-105. PubMed ID: 34298011
[TBL] [Abstract][Full Text] [Related]
3. Clonal hematopoiesis and associated diseases: A review of recent findings.
Asada S; Kitamura T
Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
[TBL] [Abstract][Full Text] [Related]
4. A new risk factor associated with cardiovascular disease: clonal hematopoiesis of indeterminate potential.
Yu X; Qian N; Wang Y
Mol Biol Rep; 2023 Mar; 50(3):2813-2822. PubMed ID: 36595120
[TBL] [Abstract][Full Text] [Related]
5. Clonal hematopoiesis and cardiovascular disease: deciphering interconnections.
Stein A; Metzeler K; Kubasch AS; Rommel KP; Desch S; Buettner P; Rosolowski M; Cross M; Platzbecker U; Thiele H
Basic Res Cardiol; 2022 Nov; 117(1):55. PubMed ID: 36355225
[TBL] [Abstract][Full Text] [Related]
6. Clinical consequences of clonal hematopoiesis of indeterminate potential.
Steensma DP
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):264-269. PubMed ID: 30504320
[TBL] [Abstract][Full Text] [Related]
7. Putative Mechanisms Underlying Cardiovascular Disease Associated with Clonal Hematopoiesis of Indeterminate Potential.
Burns SS; Kapur R
Stem Cell Reports; 2020 Aug; 15(2):292-306. PubMed ID: 32735822
[TBL] [Abstract][Full Text] [Related]
8. Clonal hematopoiesis: Genes and underlying mechanisms in cardiovascular disease development.
Haybar H; Shahrabi S; Ghanavat M; Khodadi E
J Cell Physiol; 2019 Jun; 234(6):8396-8401. PubMed ID: 30417440
[TBL] [Abstract][Full Text] [Related]
9. Clinical consequences of clonal hematopoiesis of indeterminate potential.
Steensma DP
Blood Adv; 2018 Nov; 2(22):3404-3410. PubMed ID: 30482770
[TBL] [Abstract][Full Text] [Related]
10. Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Disease.
Kumar P; Kopecky SL; Yang EH; Oren O
Curr Oncol Rep; 2020 Jul; 22(9):87. PubMed ID: 32643015
[TBL] [Abstract][Full Text] [Related]
11. Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk.
Haring B; Wissel S; Manson JE
Curr Cardiol Rep; 2022 Aug; 24(8):1049-1058. PubMed ID: 35657494
[TBL] [Abstract][Full Text] [Related]
12. Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease.
Huang YC; Wang CY
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576030
[TBL] [Abstract][Full Text] [Related]
13. Genetic modification of inflammation- and clonal hematopoiesis-associated cardiovascular risk.
Yu Z; Fidler TP; Ruan Y; Vlasschaert C; Nakao T; Uddin MM; Mack T; Niroula A; Heimlich JB; Zekavat SM; Gibson CJ; Griffin GK; Wang Y; Peloso GM; Heard-Costa N; Levy D; Vasan RS; Aguet F; Ardlie KG; Taylor KD; Rich SS; Rotter JI; Libby P; Jaiswal S; Ebert BL; Bick AG; Tall AR; Natarajan P
J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37498674
[TBL] [Abstract][Full Text] [Related]
14. Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD: JACC Review Topic of the Week.
Khetarpal SA; Qamar A; Bick AG; Fuster JJ; Kathiresan S; Jaiswal S; Natarajan P
J Am Coll Cardiol; 2019 Jul; 74(4):578-586. PubMed ID: 31345433
[TBL] [Abstract][Full Text] [Related]
15. Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases-an updated systematic review.
Senguttuvan NB; Subramanian V; Venkatesan V; Muralidharan TR; Sankaranarayanan K
J Genet Eng Biotechnol; 2021 Jul; 19(1):105. PubMed ID: 34279740
[TBL] [Abstract][Full Text] [Related]
16. Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure.
Yu B; Roberts MB; Raffield LM; Zekavat SM; Nguyen NQH; Biggs ML; Brown MR; Griffin G; Desai P; Correa A; Morrison AC; Shah AM; Niroula A; Uddin MM; Honigberg MC; Ebert BL; Psaty BM; Whitsel EA; Manson JE; Kooperberg C; Bick AG; Ballantyne CM; Reiner AP; Natarajan P; Eaton CB;
J Am Coll Cardiol; 2021 Jul; 78(1):42-52. PubMed ID: 34210413
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations.
Calvillo-Argüelles O; Schoffel A; Capo-Chichi JM; Abdel-Qadir H; Schuh A; Carrillo-Estrada M; Liu S; Gupta V; Schimmer AD; Yee K; Shlush LI; Natarajan P; Thavendiranathan P
JACC CardioOncol; 2022 Mar; 4(1):38-49. PubMed ID: 35492819
[TBL] [Abstract][Full Text] [Related]
18. Clonal Hematopoiesis of Indeterminate Potential in Chronic Thromboembolic Pulmonary Hypertension: A Multicenter Study.
Liu C; Zhou YP; Lian TY; Li RN; Ma JS; Yang YJ; Zhang SJ; Li XM; Qiu LH; Qiu BC; Ren LY; Wang J; Han ZY; Li JH; Wang L; Xu XQ; Sun K; Chen LF; Cheng CY; Zhang ZJ; Jing ZC
Hypertension; 2024 Feb; 81(2):372-382. PubMed ID: 38116660
[TBL] [Abstract][Full Text] [Related]
19. CHIP Happens: Clonal Hematopoiesis of Indeterminate Potential and Its Relationship to Solid Tumors.
Reed SC; Croessmann S; Park BH
Clin Cancer Res; 2023 Apr; 29(8):1403-1411. PubMed ID: 36454121
[TBL] [Abstract][Full Text] [Related]
20. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
Gumuser ED; Schuermans A; Cho SMJ; Sporn ZA; Uddin MM; Paruchuri K; Nakao T; Yu Z; Haidermota S; Hornsby W; Weeks LD; Niroula A; Jaiswal S; Libby P; Ebert BL; Bick AG; Natarajan P; Honigberg MC
J Am Coll Cardiol; 2023 May; 81(20):1996-2009. PubMed ID: 37197843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]